Value of silicone gel in prevention of cobblestoning following punch minigrafting in vitiligo

References

• Dillon AB, Sideris A, Hadi A, et al. Advances in vitiligo: an update on medical and surgical treatments. J Clin Aesthet Dermatol. 2017;10(1):15–28.
   PubMedGoogle Scholar
• Lahiri K. Evolution and evaluation of autologous mini punch grafting in vitiligo. Indian J Dermatol. 2009;54(2):159–167.
   PubMedGoogle Scholar
• Njoo MD, Westerhof W, Bos JD, et al. A systematic review of autologous transplantation methods in vitiligo. Arch Dermatol. 1998;134(12):1543–1549.
   PubMedGoogle Scholar
• Agarwal US, Jain D, Gulati R, et al. Silicone gel sheet dressings for prevention of post-minigraft cobblestoning in vitiligo. Dermatol Surg. 1999;25(2):102–104.
   PubMed Web of Science ®Google Scholar
• Komen L, Vrijman C, Prinsen C, et al. Optimising size and depth of punch grafts in autologous transplantation of vitiligo and piebaldism: a randomized controlled trial. J Dermatolog Treat. 2017;28(1):86–91.
   PubMed Web of Science ®Google Scholar
• Gupta S, Honda S, Kumar B. A novel scoring system for evaluation of results of autologous transplantation methods in vitiligo. Indian J Dermatol Venereol Leperol. 2002;68:33–37.
   PubMedGoogle Scholar
• Puri N, Talwar A. The efficacy of silicone gel for the treatment of hypertrophic scars and keloids. J Cutan Aesthet Surg. 2009; 2(2):104–106.
   PubMedGoogle Scholar
• Trojanowska M. Ets factors and regulation of the extracellular matrix. Oncogene. 2000;19(55):6464–6471.
   PubMed Web of Science ®Google Scholar
• Nagase H, Woessner JF. Matrix metalloproteinases. J Biol Chem. 1999;274(31):21491–21494.
   PubMed Web of Science ®Google Scholar
• Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 2003;92(8):827–839.
   PubMed Web of Science ®Google Scholar
• Midwood KS, Chiquet M, Tucker RP, et al. Tenascin-C at a glance. J Cell Sci. 2016;129(23):4321–4327.
   PubMed Web of Science ®Google Scholar
• Pollard JW. Macrophages define the invasive microenvironment in breast cancer. J Leukoc Biol. 2008;84(3):623–630.
   PubMed Web of Science ®Google Scholar
• Njoo MD, Das PK, Bos JD, et al. Association of the Koebner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris. Arch Dermatol. 1999;135(4):407–413.
   PubMedGoogle Scholar
• Leheta T, El Garem Y, Hegazy R, et al. Non-ablative 1540 fractional laser: how far could it help injection lipolysis and dermal fillers in lower-face rejuvenation? A randomized controlled trail. J Cosmet Laser Ther. 2013;15(1):13–20.
   PubMed Web of Science ®Google Scholar
• Berman B, Maderal A, Raphael B. Keloids and hypertrophic scars: pathophysiology, classification, and treatment. Dermatol Surg. 2017;43(Suppl 1):S3–S18.
   PubMedGoogle Scholar
• Ghazawi FM, Zargham R, Gilardino MS, et al. Insights into the Pathophysiology of Hypertrophic Scars and Keloids: How Do They Differ? Adv Skin Wound Care. 2018; 31(1):582–595.
   PubMed Web of Science ®Google Scholar
• Chan KY, Lau CL, Adeeb SM, et al. A randomized, placebo-controlled, double-blind, prospective clinical trial of silicone gel in prevention of hypertrophic scar development in median sternotomy wound. Plast Reconstr Surg. 2005; 116(4):1013–1020. discussion 1021–2.
   PubMed Web of Science ®Google Scholar
• Chittoria RK, Padi TR. A prospective, randomized, placebo controlled, double blind study of silicone gel in prevention of hypertrophic scar at donor site of skin grafting. J Cutan Aesthet Surg. 2013; 6(1):12–16.
   PubMedGoogle Scholar
• Kim SM, Choi JS, Lee JH, et al. Prevention of postsurgical scars: comparsion of efficacy and convenience between silicone gel sheet and topical silicone gel. J Korean Med Sci. 2014;29(Suppl 3):S249–S53.
   PubMedGoogle Scholar
• Kumar R, Parsad D, Kanwar AJ, et al. Altered levels of Ets-1 transcription factor and matrix metalloproteinases in melanocytes from patients with vitiligo. Br J Dermatol. 2011; 165(2):285–291.
   PubMed Web of Science ®Google Scholar
• Lee DE, Trowbridge RM, Ayoub NT, et al. High-mobility group box protein-1, matrix metalloproteinases, and vitamin D in keloids and hypertrophic scars. Plast Reconstr Surg Glob Open. 2015; 8(3(6):e425.
   Google Scholar
• Neely AN, Clendening CE, Gardner J, et al. Gelatinase activity in keloids and hypertrophic scars. Wound Repair Regen. 1999; 7(3):166–171.
   PubMed Web of Science ®Google Scholar
• El Mofty M, Esmat S, Hunter N, et al. Effect of different types of therapeutic trauma on vitiligo lesions. Dermatol Ther. 2017;30(2):e12447.
   PubMed Web of Science ®Google Scholar
• Le Poole IC, Van den Wijngaard RM, Westerhof W, et al. Tenascin is overexpressed in vitiligo lesional skin and inhibit melanocyte adhesion. Br J Dermatol. 1997; 137(2):171–178.
   PubMed Web of Science ®Google Scholar
• Abdou AG, Maraee AH, Shoeib MA, et al. Immunolocalization of Tenascin-C in vitiligo. Appl Immunohistochem Mol Morphol. 2012; 20(5):501–511.
   PubMedGoogle Scholar
• Laddha NC, Dwivedi M, Begum R. Increased tumor necrosis factor (TNF)-α and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo. PLoS One. 2012;7(12):e52298.
   PubMed Web of Science ®Google Scholar
• Karam RA, Zidan HE, Khater MH. Genetic variants of interferon-gamma and its mRNA expression and inflammatory parameters in the pathogenesis of vitiligo. Biochem Cell Biol. 2017; 95(4):474–481.
   PubMedGoogle Scholar
• Latijnhouwers MA, Pfundt R, de Jongh GJ, et al. Tenascin-C expression in human epidermal keratinocytes is regulated by inflammatory cytokines and a stress response pathway. Matrix Biol. 1998;17(4):305–316.
   PubMed Web of Science ®Google Scholar
• Jumper N, Paus R, Bayat A. Functional histopathology of keloid disease. Histol Histopathol. 2015; 30(9):1033–1057.
   PubMed Web of Science ®Google Scholar
• Lieber CS, Weiss DG, Paronetto F, Veterans Affairs Cooperative Study 391 Group. Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease. Alcoholism Clin Exp Res. 2008;32(6):1031–1039.
   PubMed Web of Science ®Google Scholar
• Paivaniemi OE, Maasilta PK, Alho HS, et al. Epithelial tenascin predicts obliterative airway disease. J Heart Lung Transplant. 2008;27(4):400–407.
   PubMed Web of Science ®Google Scholar
• Midwood KS, Orend G. The role of tenascin-C in tissue injury and tumorigenesis. J Cell Commun Signal. 2009; 3(3-4):287–310.
   PubMed Web of Science ®Google Scholar